Janus Henderson highlights growing investment opportunity as GLP-1 innovation accelerates

Advances in GLP-1 therapies are creating a new phase of opportunity across the healthcare sector, according to Janus Henderson Investors, as oral medicines, broader disease applications and a rapidly expanding patient population reshape one of the industry's fastest-growing markets.  The asset manager believes these developments are creating long-term opportunities not…